OXBRYTA
Live / Allowed — Published for opposition (as of 06 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99524748
- Mark type
- Design + words
- Filed
- 02 Dec 2025
- Published for opposition
- 06 Oct 2026
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of vaso-occlusive crisis; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of sickle cell disease.
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 06 Oct 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Oct 2026 — PUBLISHED FOR OPPOSITION
- 30 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Sept 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Sept 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Sept 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 15 May 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 15 May 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 May 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION E-MAILED
- 18 Mar 2026 — NON-FINAL ACTION WRITTEN